These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9548587)

  • 1. Cholesterol transport between cells and high density lipoprotein subfractions from obese and lean subjects.
    Sasahara T; Nestel P; Fidge N; Sviridov D
    J Lipid Res; 1998 Mar; 39(3):544-54. PubMed ID: 9548587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
    Marcil M; Yu L; Krimbou L; Boucher B; Oram JF; Cohn JS; Genest J
    Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):159-69. PubMed ID: 9888879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A natural apolipoprotein A-I variant, apoA-I (L141R)Pisa, interferes with the formation of alpha-high density lipoproteins (HDL) but not with the formation of pre beta 1-HDL and influences efflux of cholesterol into plasma.
    Miccoli R; Zhu Y; Daum U; Wessling J; Huang Y; Navalesi R; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jun; 38(6):1242-53. PubMed ID: 9215551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
    von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
    Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome.
    Batista MC; Welty FK; Diffenderfer MR; Sarnak MJ; Schaefer EJ; Lamon-Fava S; Asztalos BF; Dolnikowski GG; Brousseau ME; Marsh JB
    Metabolism; 2004 Oct; 53(10):1255-61. PubMed ID: 15375779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.
    Johnson WJ; Kilsdonk EP; van Tol A; Phillips MC; Rothblat GH
    J Lipid Res; 1991 Dec; 32(12):1993-2000. PubMed ID: 1816327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of smooth muscle cells to assembly of high density lipoproteins with extracellular free apolipoproteins and to reduction of intracellularly accumulated cholesterol.
    Komaba A; Li Q; Hara H; Yokoyama S
    J Biol Chem; 1992 Sep; 267(25):17560-6. PubMed ID: 1517206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects.
    Shige H; Nestel P; Sviridov D; Noakes M; Clifton P
    Metabolism; 2000 Nov; 49(11):1453-9. PubMed ID: 11092511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered properties of high density lipoprotein subfractions in obese subjects.
    Sasahara T; Yamashita T; Sviridov D; Fidge N; Nestel P
    J Lipid Res; 1997 Mar; 38(3):600-11. PubMed ID: 9101441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
    Jin FY; Kamanna VS; Kashyap ML
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the propeptide of apolipoprotein A-I reduces protein expression but stimulates effective conversion of prebeta-high density lipoprotein to alpha-high density lipoprotein.
    Sviridov D; Pyle LE; Jauhiainen M; Ehnholm C; Fidge NH
    J Lipid Res; 2000 Nov; 41(11):1872-82. PubMed ID: 11060357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein A-IFIN (Leu159-->Arg) mutation affects lecithin cholesterol acyltransferase activation and subclass distribution of HDL but not cholesterol efflux from fibroblasts.
    Miettinen HE; Jauhiainen M; Gylling H; Ehnholm S; Palomäki A; Miettinen TA; Kontula K
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3021-32. PubMed ID: 9409289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans.
    Nanjee MN; Cooke CJ; Garvin R; Semeria F; Lewis G; Olszewski WL; Miller NE
    J Lipid Res; 2001 Oct; 42(10):1586-93. PubMed ID: 11590214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-Density Lipoprotein Subfractions and Cholesterol Efflux Capacities After Infusion of MDCO-216 (Apolipoprotein A-IMilano/Palmitoyl-Oleoyl-Phosphatidylcholine) in Healthy Volunteers and Stable Coronary Artery Disease Patients.
    Kempen HJ; Asztalos BF; Moerland M; Jeyarajah E; Otvos J; Kallend DG; Bellibas SE; Wijngaard PL
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):736-42. PubMed ID: 26916733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II.
    Lagrost L; Dengremont C; Athias A; de Geitere C; Fruchart JC; Lallemant C; Gambert P; Castro G
    J Biol Chem; 1995 Jun; 270(22):13004-9. PubMed ID: 7768892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lecithin:cholesterol acyltransferase reaction on cellular lipid released by free apolipoprotein-mediated efflux.
    Czarnecka H; Yokoyama S
    Biochemistry; 1995 Apr; 34(13):4385-92. PubMed ID: 7703252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipid transfer protein mediated conversion of high density lipoproteins generates pre beta 1-HDL.
    von Eckardstein A; Jauhiainen M; Huang Y; Metso J; Langer C; Pussinen P; Wu S; Ehnholm C; Assmann G
    Biochim Biophys Acta; 1996 Jun; 1301(3):255-62. PubMed ID: 8664337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between cholesterol efflux and high-density lipoprotein particles in patients with type 2 diabetes mellitus.
    Tan HC; Tai ES; Sviridov D; Nestel PJ; Ng C; Chan E; Teo Y; Wai DC
    J Clin Lipidol; 2011; 5(6):467-73. PubMed ID: 22108150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of cholesterol efflux in humans after infusion of reconstituted high-density lipoprotein.
    Hoang A; Drew BG; Low H; Remaley AT; Nestel P; Kingwell BA; Sviridov D
    Eur Heart J; 2012 Mar; 33(5):657-65. PubMed ID: 21498847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.